Chronic lymphocytic leukemia (CLL)
NGS panel for the study of 23 key genes associated with Chronic Lymphocytic Leukemia (CLL), including the biomarkers outlined in international guidelines (TP53 and somatic hypermutation).
Archer VariantPlex Comprehensive Thyroid & Lung Kit
CatalogOncologySolid Tumor
NGS assay for the study of 31 genes involved in thyroid and lung cancer
The Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit is an NGS-based targeted sequencing assay to detect CNVs, SNVs and indels in 31 thyroid and lung cancer-implicated genes.
The kit covers entire targeted exons while maintaining high coverage uniformity (> 95%) and on-target reads (99.9%). When used alongside the RNA-based FusionPlex® CTL Kit, fusions, SNVs, CNVs and expression profiles can be analyzed from a single low-input FFPE sample. Archer Analysis software allow the analysis and interpretation of the data.
Genes:
Archer® Solid Tumor assays provide a targeted sequencing approach to detect various driver mutation types in solid tumors. This approach combines FusionPlex®, VariantPlex® and Reveal ctDNA™ kits to characterize gene fusions, expression, CNVs and other variants from a single, low-input FFPE sample and liquid biopsy.
Archer VariantPlex Comprehensive Thyroid & Lung Kit
| Product | Reference |
|---|---|
| VariantPlex® CTL Kit, for Illumina®- 8 reactions | AB0077 |
| VariantPlex®CTL Starter Kit, for Illumina® - 16 reactions | AB0079 |
| VariantPlex®CTL Kit, for Illumina® - 48 reactions | AB0081 |
Public Documentation
